/EWTX

Edgewise Therapeutics Inc

EWTX

$44.40USD↑+3.50%+1.50 today

MARKET CAP

4.8B

P/E (TTM)

—

FWD P/E

39.5x

DAY RANGE

$43 – $45

52W RANGE

$14

$48

AI Summary

Stalk

StalkMedium

While the medium-term structure remains bullish with a Stage 2 advance and a recent momentum breakout above consolidation, short-term exhaustion at the highs and extended price above EMAs suggest timing is poor. Execution is best deferred to a pullback into the rising EMAs and 50 SMA for an asymmetric entry.

↑12-week Phase 2 CIRRUS-HCM showed EDG-7500 efficacy, prompting JPMorgan PT increase to $60
↑13F ownership at 3.06% reflects strong hedge fund confidence
↓Earnings yield of –1.88% and weak profitability undermine valuation

Full analysis →

Buying

8

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
JH Janus Henderson Group Plc Q1 2026	BUY	11.83 M	372.58 M	+7.26 M	+228.8%	0.09%
RC Ra Capital Management, L.P. Q2 2026	SELL	8.39 M	341.00 M	+-2.04 M	+3.8%	2.97%
BI Blackrock, Inc. Q2 2026	BUY	6.61 M	268.42 M	+133.34 K	+31.6%	0.00%
PA Perceptive Advisors LLC Q2 2026	SELL	4.37 M	177.71 M	+-4.47 M	-36.2%	2.67%
CA Citadel Advisors LLC Q2 2026	BUY	530.81 K	21.57 M	+47.08 K	+41.5%	0.00%
WP Woodline Partners LP Q2 2026	SELL	224.29 K	9.11 M	+-224.29 K	-35.5%	0.03%
JC Jpmorgan Chase & Co Q2 2026	BUY	203.15 K	8.48 M	+55.58 K	+89.7%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	BUY	143.20 K	5.82 M	+52.60 K	+103.9%	0.27%
PA Point72 Asset Management, L.P. Q2 2026	BUY	131.86 K	5.36 M	+117.26 K	+1064.9%	0.01%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	26.57 K	1.08 M	+26.57 K	+0.0%	0.01%
AC Aqr Capital Management LLC Q2 2026	BUY	18.46 K	749.87 K	+9.92 K	+178.8%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	324.00	13.16 K	+-408.00	-42.9%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-342.87 K	-100.0%	0.00%